It is not OK for physicians ’ anxieties to harm their patients PODCAST

“It is OK to be scared, but it is not OK to let our own anxieties harm our patients. As we tackle the numerous crises created by the COVID-19 pandemic, let ’s acknowledge our fear and draw on the logic and clinical reasoning that we have spent years cultivating. We can be scared and scientific, anxious, […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Podcast COVID-19 coronavirus Hospital-Based Medicine Infectious Disease Source Type: blogs

Related Links:

Authors: Wong A, Keith C, Gregory H, Liew D Abstract COVID-19 brings with it unprecedented challenges in clinical management. An important component of care is the provision of safe and effective symptom control. Given the emerging literature reporting on the risk of QT prolongation and arrhythmias associated with COVID-19 disease and experimental therapies, we highlight some considerations for the prescribing of palliative care medications in this context. Based on the experience gained from palliative care referrals at our institution prior to and during the COVID-19 pandemic, and in collaboration with our clinic...
Source: Journal of Pain and Palliative Care Pharmacotherapy - Category: Palliative Care Tags: J Pain Palliat Care Pharmacother Source Type: research
Publication date: November 2020Source: Epilepsy &Behavior, Volume 112Author(s): Mehri Salari, Masoud Etemadifar, Koroush Gharagozli, Koorosh Etemad, Farzad Ashrafi, Helia Ashourizadeh
Source: Epilepsy and Behavior - Category: Neurology Source Type: research
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
Source: New Scientist - Health - Category: Consumer Health News Source Type: research
Publication date: Available online 22 September 2020Source: Journal of Anxiety DisordersAuthor(s): Rebecca C. Cox, Sarah C. Jessup, Maxwell J. Luber, Bunmi O. Olatunji
Source: Journal of Anxiety Disorders - Category: Psychiatry Source Type: research
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4730668","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Beth Israel Deacones Medical Center Coronavirus Johnson & Johnson Source Type: news
(Natural News) The ongoing Wuhan coronavirus (COVID-19) pandemic, including federal relief efforts to blunt its impact on the economy, will cloud the U.S.’s long-term fiscal outlook for decades to come. This analysis comes from the Congressional Budget Office (CBO), which released new forecasts Monday, showing that federal debt will likely surge to 104 percent in 2021 and be...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Dr. Anthony Fauci said if the vaccine works, it could be “especially useful” in curbing the pandemic.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Breaking breaking-news Coronavirus Source Type: news
NEW BRUNSWICK, N.J., September 23, 2020 – Johnson &Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile and immunogenicity after a single vaccination were supportive of further development. These results have been submitted to medRxiv and are due to be published online im...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news
Here's what to expect with gatherings and activities over the colder months of the coronavirus pandemic.
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Discussion: The success of the CCF could be attributed to the use of a facility of opportunity, strong interorganizational and cross-sector cooperation, an integrated and robust clinical system, and clear communication channels. It allows for efficient resource utilization and is valuable in future pandemics with similar disease characteristics.
Source: Journal of Public Health Management and Practice - Category: Health Management Tags: Research Reports Source Type: research
More News: Blogging | Coronavirus | COVID-19 | General Medicine | Hospitals | Infectious Diseases | Jobs | Learning | Pandemics | Podcasts | Universities & Medical Training